We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.83%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
+$2.18B
(+5%)
Cap. Flow
+$425M
Cap. Flow
% of AUM
0.92%
Top 10 Holdings %
Top 10 Hldgs %
15.17%
Holding
2,954
New
28
Increased
2,252
Reduced
604
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$128M |
| 2 |
Baker Hughes
BKR
|
+$26.7M |
| 3 |
IQVIA
IQV
|
+$14.5M |
| 4 |
Oneok
OKE
|
+$14.3M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$11.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$114M |
| 2 |
RAI
Reynolds American Inc
RAI
|
+$88.6M |
| 3 |
BHI
Baker Hughes
BHI
|
+$41.6M |
| 4 |
WFM
Whole Foods Market Inc
WFM
|
+$26.7M |
| 5 |
UnitedHealth
UNH
|
+$22.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.64% |
| 2 | Technology | 15.8% |
| 3 | Healthcare | 13.57% |
| 4 | Industrials | 10.87% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TREC
2526
DELISTED
Trecora Resources
TREC
| $323K | ﹤0.01% |
24,262
+130
| +0.5% | +$1.58K |
|
2527
Energy Recovery
ERII
$446M
| $322K | ﹤0.01% |
40,747
+640
| +2% | +$4.57K |
|
2528
Limoneira
LMNR
$235M
| $322K | ﹤0.01% |
13,918
+80
| +0.6% | +$1.78K |
|
2529
Preformed Line Products
PLPC
$1.75B
| $320K | ﹤0.01% |
4,758
+27
| +0.6% | +$1.42K |
|
2530
Omega Flex
OFLX
$297M
| $319K | ﹤0.01% |
4,441
+30
| +0.7% | +$1.88K |
|
2531
Primis Financial Corp
FRST
$399M
| $318K | ﹤0.01% |
18,694
+6,425
| +52% | +$108K |
|
2532
Medpace
MEDP
$16.1B
| $317K | ﹤0.01% |
9,938
+212
| +2% | +$6.48K |
|
|
CIVI
2533
DELISTED
Civitas Solutions, Inc.
CIVI
| $316K | ﹤0.01% |
17,112
+215
| +1% | +$3.92K |
|
|
BSTC
2534
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $315K | ﹤0.01% |
6,777
+110
| +2% | +$5.27K |
|
2535
Cerus
CERS
$433M
| $314K | ﹤0.01% |
115,131
+1,405
| +1% | +$3.44K |
|
|
ZIXI
2536
DELISTED
Zix Corporation
ZIXI
| $314K | ﹤0.01% |
64,235
+1,025
| +2% | +$5.4K |
|
2537
Reading International Class A
RDI
$33.2M
| $313K | ﹤0.01% |
19,885
+170
| +0.9% | +$2.69K |
|
|
AT
2538
DELISTED
Atlantic Power Corporation
AT
| $312K | ﹤0.01% |
127,290
+575
| +0.5% | +$1.38K |
|
|
BGFV
2539
DELISTED
Big 5 Sporting Goods
BGFV
| $311K | ﹤0.01% |
40,590
+1,350
| +3% | +$12.5K |
|
|
AXAS
2540
DELISTED
Abraxas Petroleum Corp
AXAS
| $311K | ﹤0.01% |
8,261
+123
| +2% | +$4.18K |
|
2541
Liquidity Services
LQDT
$1.22B
| $309K | ﹤0.01% |
52,362
+1,280
| +3% | +$7.8K |
|
2542
FreightCar America
RAIL
$261M
| $309K | ﹤0.01% |
15,814
+150
| +1% | +$2.64K |
|
|
RETA
2543
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $309K | ﹤0.01% |
9,927
+350
| +4% | +$10.5K |
|
2544
Daily Journal
DJCO
$809M
| $307K | ﹤0.01% |
1,403
+27
| +2% | +$5.69K |
|
2545
iShares Russell 2000 Value ETF
IWN
$14.3B
| $307K | ﹤0.01% |
2,475
-2,865
| -54% | -$338K |
|
|
STML
2546
DELISTED
Stemline Therapeutics, Inc.
STML
| $307K | ﹤0.01% |
27,648
+290
| +1% | +$2.73K |
|
|
SNBC
2547
DELISTED
Sun Bancorp Inc
SNBC
| $306K | ﹤0.01% |
12,306
+60
| +0.5% | +$1.43K |
|
|
DRRX
2548
DELISTED
DURECT Corp
DRRX
| $304K | ﹤0.01% |
17,189
-371
| -2% | -$6.22K |
|
2549
Ceco Environmental
CECO
$3.85B
| $303K | ﹤0.01% |
35,873
+470
| +1% | +$4.04K |
|
2550
Cadiz
CDZI
$251M
| $302K | ﹤0.01% |
23,814
+415
| +2% | +$5.05K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2017 Portfolio in Review
As of Q3 2017, RhumbLine Advisers held 2,954 positions worth $46B, up 5% from $43.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q3 2017: portfolio turnover was 2.6%. RhumbLine Advisers opened 28 new positions and exited 50, leaving the 2,954-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q3 2017 buy was Baker Hughes: 750,985 shares worth $27.5M.
- RhumbLine Advisers added most to DuPont de Nemours in Q3 2017, an estimated $128M increase.
- RhumbLine Advisers's biggest Q3 2017 reduction was UnitedHealth, cutting an estimated $22.8M.
- RhumbLine Advisers fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $114M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $46B portfolio in Q3 2017.
- RhumbLine Advisers opened 28 new positions and closed 50 in Q3 2017.
- RhumbLine Advisers's portfolio value rose 5% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q3 2017, filed 6 Nov 2017.